Incyte earnings were $21.3M for the trailing 12 months ending Mar 31, 2025, with -91.3% growth year over year. The latest INCY earnings report on Mar 31, 2025 announced Q1 2025 earnings of $158.2M, down 21.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INCY reported annual earnings of $32.6M, with -94.5% growth.
INCY past earnings growth
How has INCY's earnings growth performed historically?
On INCY's earnings call on Invalid Date, Incyte (NASDAQ: INCY) reported Q1 2025 earnings per share (EPS) of $0.82, up 7.89% year over year. Total INCY earnings for the quarter were $158.20 million. In the same quarter last year, Incyte's earnings per share (EPS) was $0.76.
As of the last Incyte earnings report, Incyte is currently profitable. Incyte's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $21.27 million, a 97.15% decrease year over year.
What was INCY's earnings growth in the past year?
As of Incyte's earnings date in Invalid Date, Incyte's earnings has grown -91.29% year over year. This is 103.29 percentage points lower than the US Biotechnology industry earnings growth rate of 12%. INCY earnings in the past year totalled $21.27 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.